Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) shares hit a new 52-week low during trading on Tuesday . The stock traded as low as $3.19 and last traded at $3.23, with a volume of 5491 shares traded. The stock had previously closed at $3.24.
Hypera Stock Performance
The company has a 50-day moving average of $4.16 and a 200 day moving average of $4.90.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- What is the Dow Jones Industrial Average (DJIA)?
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Stock Sentiment Analysis: How it Works
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
